{"id":1180,"date":"2021-06-27T05:29:05","date_gmt":"2021-06-27T05:29:05","guid":{"rendered":"https:\/\/emergencydrug.com\/?post_type=product&p=1180"},"modified":"2024-09-30T06:24:57","modified_gmt":"2024-09-30T06:24:57","slug":"lorbrexen-lorlatinib-100-mg","status":"publish","type":"product","link":"https:\/\/emergencydrug.com\/ar\/shop\/lorbrexen-lorlatinib-100-mg\/","title":{"rendered":"Lorbrexen (Lorlatinib) 100 MG – 30 Tablets"},"content":{"rendered":"

Product Features:<\/em><\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
Product Name<\/td>\n: Lorbrexen<\/td>\n<\/tr>\n
Generic Name<\/td>\n: Lorlatinib<\/td>\n<\/tr>\n
Manufacturer<\/td>\n: Everest Pharma Ltd<\/td>\n<\/tr>\n
Indication<\/td>\n: Non small cell lung cancer<\/td>\n<\/tr>\n
Formulation<\/td>\n: Tablet<\/td>\n<\/tr>\n
Strength<\/td>\n: 100 mg<\/td>\n<\/tr>\n
Quantity<\/td>\n: 30 Tablets<\/td>\n<\/tr>\n
Storage<\/td>\n: \u00a0Below 25\u00b0C<\/td>\n<\/tr>\n
Registrations<\/td>\n: Export Only<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Lorbrexen 100 mg<\/strong>\u00a0(Lorlatinib), generic Lorbrena is a prescription medicine. It is used to treat metastatic non-small cell lung cancer<\/a> in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. These uses in patients who have already received alectinib, ceritinib or both crizotinib. At least 1 other medicine to treat NSCLC that is caused by the ALK gene.<\/p>\n

\n

Recommended Dosage<\/h4>\n

The recommended dosage of LORBRENA is 100 mg orally once daily, with or without food, until disease progression or unacceptable toxicity<\/a>.<\/p>\n

Swallow tablets whole and chew, crush or split tablets. Do not ingest broken tablets, cracked, or otherwise not intact.<\/p>\n

Take Lorbrexen at the same time each day<\/a>. One dose is missed, then take the missed dose. Unless the next dose is due within 4 hours. Please not take 2 doses at the same time to make up for a missed dose<\/a>.<\/p>\n

Do not take an additional dose if vomiting occurs after Lorbrexen but continue with the next scheduled dose.<\/p>\n<\/div>\n

\n

Lorlatinib Dosage Modifications for Adverse Reactions<\/h4>\n

\u200b<\/span>The recommended dose reductions are:<\/span><\/p>\n

\u200b<\/span>First dose reduction: Lorbrexen 100 mg orally once daily<\/a>. <\/span>Second dose reduction: LORBRENA 50 mg orally once daily\u00a0<\/span><\/p>\n<\/div>\n

Disease interactions Lorlatinib 100 mg<\/h4>\n

There are 8 disease interactions with Lorbrexen which include:<\/p>\n